Cetirizine Hydrochloride Solution
Product Images NDC 16571-134

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Cetirizine Hydrochloride (NDC 16571-134). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Cetirizine Structure)

Chemical structure of cetirizine hydrochloride, a compound shown with chlorophenyl groups, piperazine ring, and carboxyl group consistent with the generic name provided.*

FDA Label Image

Citrizine-hcl-120ml-1 (Citrizine HCl 120ml 1)

Label for CETIRIZINE HYDROCHLORIDE oral solution, USP, 1 mg/mL (5 mg/5 mL) by Rising Pharma Holdings, Inc. The product is grape flavored and intended for oral use only. The label includes storage instructions, dosage form, package size of 4 fl. oz. (120 mL), and a barcode.*

FDA Label Image

Citrizine-hcl-120ml-2 (Citrizine HCl 120ml 2)

Text panel titled DESCRIPTION and CLINICAL PHARMACOLOGY for Cetirizine Hydrochloride oral solution 1 mg/mL. It includes the chemical structure of cetirizine hydrochloride, a description of the drug as a crystalline powder in a colorless to slightly yellow oral solution, and inactive ingredients. The pharmacology section details the mechanism of action, absorption, distribution, and metabolism of cetirizine based on clinical studies.*

FDA Label Image

Citrizine-hcl-120ml-3 (Citrizine HCl 120ml 3)

This image shows detailed pharmacokinetic and pharmacodynamic information about cetirizine hydrochloride. It includes data on elimination half-life, interaction studies with other drugs, special populations such as pediatric patients, effects of gender, race, and various clinical study results focusing on cetirizine's effect on wheal and flare response, histamine release, and QTc intervals.*

FDA Label Image

Citrizine-hcl-120ml-4 (Citrizine HCl 120ml 4)

This image shows the 'Indications and Usage,' 'Contraindications,' and 'Precautions' sections for cetirizine hydrochloride oral solution, USP. It details approved uses for perennial allergic rhinitis and chronic urticaria, contraindications including hypersensitivity to cetirizine or hydroxyzine, and precautions regarding mental alertness and potential impairment during concurrent alcohol or CNS depressant use.*

FDA Label Image

Citrizine-hcl-120ml-5 (Citrizine HCl 120ml 5)

A text panel discussing drug-drug interactions and carcinogenesis, mutagenesis, and impairment of fertility for cetirizine hydrochloride. It covers the lack of significant drug interactions at low doses with certain drugs, results from carcinogenicity studies in rats and mice at various dosages, and findings on mutagenicity and reproductive performance in animal studies.*

FDA Label Image

Citrizine-hcl-120ml-6 (Citrizine HCl 120ml 6)

A text panel titled Pediatric Use and Adverse Reactions for cetirizine hydrochloride oral solution. It details safety and efficacy data in pediatric patients, dosage information, and adverse reactions observed in clinical trials involving children aged 6 months to 11 years.*

FDA Label Image

Citrizine-hcl-120ml-7 (Citrizine HCl 120ml 7)

A table titled 'Adverse Experiences Reported in Pediatric Patients Aged 6 to 11 Years' comparing the frequency of side effects occurring in placebo versus cetirizine hydrochloride 5 mg and 10 mg doses from placebo-controlled U.S. trials. Listed adverse experiences include headache, pharyngitis, abdominal pain, coughing, somnolence, diarrhea, epistaxis, bronchospasm, nausea, and vomiting with respective percentages for each group. Additional text describes infrequent events observed in broader populations and lists various system-specific adverse reactions associated with cetirizine hydrochloride.*

FDA Label Image

Citrizine-hcl-120ml-8 (Citrizine HCl 120ml 8)

A drug information panel for Cetirizine Hydrochloride oral solution, USP, 1 mg/mL, detailing vision and body side effects, overdose information, drug abuse and dependence, dosage and administration for children with chronic urticaria and allergic rhinitis, how the product is supplied, storage conditions, and distributor information for Rising Pharma Holdings, Inc. The text includes warnings, dosing instructions, and packaging sizes of 4 fl. oz. and 16 fl. oz.*

FDA Label Image

Citrizine-hcl-120ml-9 (Citrizine HCl 120ml 9)

Label for CETIRIZINE HYDROCHLORIDE oral solution, USP, 1 mg/mL (5 mg/5 mL) grape flavored, human prescription drug by Rising Pharma Holdings, Inc. The 4 fl. oz. (120 mL) container label includes storage instructions, dosage note, and a barcode, specifying it is for oral use only and Rx only.*

FDA Label Image

Citrizine-hcl-480ml-1 (Citrizine HCl 480ml 1)

Label for CETIRIZINE HYDROCHLORIDE oral solution USP 1 mg/mL (5 mg/5 mL) by Rising Pharmaceuticals. The 16 fl. oz. (480 mL) bottle is grape flavored and intended for oral use only. The label includes storage instructions, a barcode, and indicates prescription use (Rx Only). Distributed by Rising Pharma Holdings, Inc.*

FDA Label Image

Citrizine-hcl-480ml-2 (Citrizine HCl 480ml 2)

Text panel containing detailed clinical pharmacology information for Cetirizine Hydrochloride oral solution, including the drug's description, mechanism of action, pharmacokinetics (absorption, distribution, metabolism, elimination), interaction studies, effects in special populations, and pharmacodynamics. It covers study findings on absorption rates, protein binding, metabolism, elimination half-life, drug interactions, and effects in pediatric patients, gender, and race.*

FDA Label Image

Citrizine-hcl-480ml-3 (Citrizine HCl 480ml 3)

Drug information text panel for cetirizine hydrochloride oral solution 1 mg/mL by Rising Pharma Holdings, Inc. This panel includes clinical study summaries, indications and usage for perennial allergic rhinitis and chronic urticaria, contraindications, precautions regarding mental alertness, drug-drug interactions, carcinogenicity, mutagenesis, fertility impairment, pediatric use, and adverse reactions.*

FDA Label Image

Citrizine-hcl-480ml-4 (Citrizine HCl 480ml 4)

Drug safety information for Cetirizine Hydrochloride oral solution 1 mg/mL includes adverse experiences reported in pediatric patients aged 6 to 11 years from placebo-controlled trials, a detailed table of adverse events, and additional safety concerns such as autonomic, cardiovascular, neurological, gastrointestinal, genitourinary, hearing, metabolic, musculoskeletal, psychiatric, respiratory, reproductive, skin, and vision effects. The panel also covers post-marketing experience, drug abuse and dependence, and overdose information.*

FDA Label Image

Citrizine-hcl-480ml-5 (Citrizine HCl 480ml 5)

Cetirizine Hydrochloride Oral Solution, USP 1 mg/mL (5 mg/5 mL) by Rising Pharmaceuticals. This grape-flavored oral solution is for oral use only, supplied in a 16 fl. oz. (480 mL) bottle. Label includes dosing, storage instructions at 20-25°C with permitted excursions, and refrigeration guidelines. NDC 16571-134-48, Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.